Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma | MicrobiomeTrials← Back to trialsNCT06492915
Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-08-13Est. Completion: 2027-02-28
Enrollment target: 42 participants Locations- Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Other microbiome trials you might be interested in
Pancreatic Carcinoma
This study investigates how often abnormal findings from routine magnetic resonance imaging occur in people with genetic…
San Francisco, United StatesCompleted Oct 19, 2026
CancerPDAC - Pancreatic Ductal AdenocarcinomaNSCLC (Non-small Cell Lung Cancer)CRC (Colorectal Cancer)Advanced Solid Tumors
The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumor…
Orlando, United StatesEst. completion May 2029
Malignant Solid TumorsOther Neoplasms Solid TumorsPediatric Solid TumorRefractory Solid TumorsSolid Tumor
Background:
Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors or…
Bethesda, United StatesEst. completion May 31, 2028